Summary
This large UK Biobank study characterizes relationships between circulating blood proteins and the incidence of 23 age-related diseases, identifying over 3,200 protein–disease associations across 963 proteins. Protein-based risk prediction scores outperformed conventional biomarkers and lifestyle factors for six conditions, notably surpassing both polygenic risk scores and HbA1c in predicting type 2 diabetes onset. The findings demonstrate the clinical utility of the plasma proteome for early risk stratification in ageing-related disease.
UK applicability
As this study was conducted within the UK Biobank, its findings are directly applicable to UK population health and clinical practice. The proteomic biomarkers and risk prediction models derived here could inform future UK preventive health strategies and risk assessment algorithms for age-related diseases in primary and secondary care.
Key measures
1,468 Olink protein levels; area under the curve (AUC) for 10-year disease prediction; ProteinScore performance versus polygenic risk scores and HbA1c for type 2 diabetes; comparison with metabolomic features
Outcomes reported
The study identified 3,209 associations between 963 circulating protein levels and 21 incident age-related disease outcomes and mortality in a cohort of 47,600 UK Biobank participants. Protein-based risk scores (ProteinScores) were developed and validated for their ability to predict 10-year disease onset beyond conventional risk factors.
Topic tags
Dig deeper with Pulse AI.
Pulse AI has read the whole catalogue. Ask about this record, its theme, or how the findings apply to UK farming and policy — every answer cites the underlying studies.